[Pharmacological effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil), with special reference to its effects on isolated arteries].
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001158:Arteries / Q000187:drug effects*; D001464:Barium / Q000037:antagonists & inhibitors; D002536:Cerebral Arteries / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D005263:Femoral Artery / Q000187:drug effects; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D008638:Mesenteric Arteries / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D011189:Potassium Chloride / Q000037:antagonists & inhibitors; D011817:Rabbits; D012077:Renal Artery / Q000187:drug effects; D012702:Serotonin Antagonists
D006634:Histamine H1 Antagonists; D010880:Piperidines; D012702:Serotonin Antagonists; D000804:Angiotensin II; D001464:Barium; D010665:Phenylpropanolamine; D011189:Potassium Chloride; D010208:Papaverine; D009638:Norepinephrine